Pharmacy Podcast Network

Welcome back to season 9! We’re kicking it off with my first powerhouse guest, whose mission is to bring clarity, safety, and evidence-based understanding to hyperbaric oxygen therapy and integrative wellness. There is a growing wave of interest in longevity and recovery therapies, but also a lot of confusion and misinformation. She breaks down the science (and safety) of one of the most powerful, foundational tools we have for reducing inflammation, accelerating healing, and supporting long-term health. Nicole Garrett is the CEO of Under Pressure Hyperbarics, a premier hyperbaric oxygen therapy center in Beverly Hills recognized for its clinical-grade safety standards and results-driven approach to wellness. With nearly two decades of experience in hyperbaric medicine, her career began as a commercial diver and dive medic, where she first learned the life-saving applications of pressure and oxygen in extreme environments.Since then, Nicole has helped open and operate HBOT centers across the country and has become a trusted leader in the field. Her work bridges the gap between medical-grade hyperbaric therapy and modern holistic wellness, offering patients a safe and effective path to healing, recovery, and long-term vitality. Nicole is especially passionate about educating clinicians, patients, and the wellness community on the science, indications, and proper protocols behind hyperbaric therapy.Today, she leads a multidisciplinary team at Under Pressure Hyperbarics that supports surgical recovery, sports performance, chronic inflammation, and overall health optimization using hospital-grade chambers and evidence-aligned treatment plans.Connect with Nicole via:Email: [email protected] Website: Under Pressure HyperbaricsFB: Under Pressure HyperbaricsIG: @underpressurehyperbaricsLinked In: Under Pressure Hyperbarics

Welcome to this special three-part press coverage series from the Pharmacy Podcast Network, recorded on location at the Pennsylvania Pharmacists Association Annual Conference, held February 20th through the 22nd at the Hilton Harrisburg. This series is proudly sponsored by Value Drug Company and the Pennsylvania Pharmacists Care Network — PPCN — as they celebrate their 10th anniversary of advancing pharmacist-led patient care across the Commonwealth.   In this episode we hear from: Margie Lydon - Value Drug Company Darren Mensch, PharmD, BCPS, BCACP Hayleigh Monroe - P4 Pharmacy Student Mayank (Dr. Mak) Amin, PharmD, RPh, MBA  Todd Laser - Value Drug Company Jonathan Adly - TJM Labs  Jennifer (Pekich) Urso  

Welcome to another episode of TWIRx – This Week in Pharmacy, where we break down the most important developments impacting the pharmacy profession. This week’s show features leaders from across community pharmacy, health systems, healthcare advocacy, and international patient engagement. From PBM reform to patient-centered care and health system growth in Western Pennsylvania, this episode brings together voices shaping the future of pharmacy. Sponsored by Sykes & Company, P.A.Accounting, tax strategy, and advisory services dedicated exclusively to independent pharmacy operators. Segment 1 Austin Murray Communications and Marketing Director – Sykes & Company, P.A. We kick off TWIRx with Austin Murray from Sykes & Company, discussing the NCPA Consumer Marketing Campaign designed to educate the public about the value of community pharmacies. Austin shares insights on: • The importance of telling the community pharmacy story directly to consumers• Why independent pharmacies remain essential healthcare access points• The evolving state of independent pharmacy nationwide• Continued momentum around PBM Reform• Strategic accounting and tax advantages pharmacy operators should understand in today’s challenging reimbursement environment Austin also explains how pharmacy-focused accounting firms like Sykes & Company help owners navigate reimbursement pressure, tax planning, and business strategy. Segment 2 Mark Duman Pharmacy 50 Award Winner – United Kingdom International healthcare thought leader Mark Duman joins TWIRx to discuss one of the most important principles in healthcare transformation: The patient must come first. Mark shares his perspective on: • Why healthcare systems must remain patient-centered• How pharmacy can lead the way in improving patient outcomes• Lessons learned from patient engagement initiatives in the UK healthcare system• Why meaningful healthcare innovation always begins by focusing on the patient experience Mark emphasizes that when healthcare professionals keep the patient as the constant focus, better pharmacy care and stronger health systems follow. Segment 3 Dr. Laura Mark, PharmD Vice President of Pharmacy – Allegheny Health Network Next, we welcome Dr. Laura Mark, Vice President of Pharmacy at Allegheny Health Network (AHN), who shares exciting news about new pharmacy operations facilities recently built in Butler County, Pennsylvania. Todd and Laura also reflect on their shared roots growing up in Butler County, while discussing how AHN is investing in the future of pharmacy. Topics include: • The new pharmacy operations infrastructure in Western Pennsylvania• How AHN is expanding pharmacy services across the Greater Pittsburgh region• The role of health system pharmacy in improving access to care• Strategic positioning for future healthcare growth and integration AHN continues to strengthen its pharmacy operations as a key component of coordinated patient care throughout the region. Segment 4 Eric Pusey Independent Pharmacy Owner – Pennsylvania Closing out this week’s episode, pharmacy owner Eric Pusey joins TWIRx to discuss the latest updates on PBM Reform in Pennsylvania.In 2024, Pennsylvania enacted Act 77, a landmark law aimed at increasing oversight and fairness in pharmacy benefit management. Eric explains how the law:• Grants new regulatory authority to the Pennsylvania Insurance Department• Restricts PBM patient steering to pharmacies owned or affiliated with benefit managers• Improves transparency requirements for PBM operations• Establishes payment protections intended to level the playing field for community pharmacies Patient steering practices have long limited competition and reduced patient choice. Eric shares why these reforms represent an important step toward protecting both patients and independent pharmacy providers across the Commonwealth. Listen & Subscribe Stay informed on the business, policy, and innovation shaping the pharmacy profession. Fol

In this episode, listeners get to know the leadership of the California Pharmacists Association (CPhA), exploring their professional journeys, personal backgrounds, and the experiences that shaped their commitment to advancing the pharmacy profession. Susan Bonilla, CEO of the California Pharmacists Association, joins Dr. Sean Kim, PharmD, Vice President of Practice & Professional Development at CPhA, to discuss California’s progress in pharmacy benefit manager (PBM) reform. As the largest state in the nation, California continues to play a significant role in shaping policies that strengthen patient access to pharmacy care and improve transparency within the prescription drug supply chain. Bonilla and Kim share insights into the reforms California has achieved, the legislative and regulatory priorities currently underway, and how these efforts may influence PBM reform conversations across the country. The PBM Reform Podcast is sponsored by the American Pharmacy Cooperative, Inc. (APCI). APCI’s sponsorship supports the production of this program but does not imply affiliation with the individual guests, nor endorsement of the views, opinions, or insights shared by podcast hosts or guests. APCI does not endorse any statements or content discussed on the PBM Reform Podcast or across the Pharmacy Podcast Network. Please reach out to the APCI Communication's team for additional information. 

In this edition of Essential, we look at two major issues facing pharmacy compounding. First is a state-by-state effort by pharma companies to pass laws restricting compounding, and second is a cryptic statement from the FDA about  possible limitations on compounding with GLP-1 ingredients. They’re both Very Big Deals for pharmacists across the country.LinksFDA statement on GLP-1 drugs: https://www.fda.gov/news-events/press-announcements/fda-intends-take-action-against-non-fda-approved-glp-1-drugs… and APC’s response: https://a4pc.org/news/apc-responds-to-fdas-glp-1-statement Stay up to date on our state Compounding Defense Initiative: compounding.com Join APC today: https://a4pc.org/membership Find us on social:LinkedIn: https://www.linkedin.com/company/a4pcrx/Facebook: https://www.facebook.com/a4pcrx/Instagram: https://www.instagram.com/a4pcrx/